Poland· PL-100536407
Ilumira
A other therapeutic radiopharmaceuticals product containing lutetium (177lu) chloride, registered in Poland by SHINE Europe B.V.. The same ATC class is registered in 8 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Lutetium (177lu) chloride is registered in 8 of 19 countries.
Countries holding a registration under ATC V10X (other therapeutic radiopharmaceuticals), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Lutetium (177lu) chloride · ATC V10X
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Lutetium (177Lu) Chloride
- Manufacturer
- SHINE Europe B.V.
- Country
- Poland (PL)
- ATC code
- V10X
- ATC class
- OTHER THERAPEUTIC RADIOPHARMACEUTICALS
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lutetium (177lu) chloride in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEndolucinBetaITM Medical Isotopes GmbH
- SwedenEndolucinBeta 40 GBq/ml Stamlösning till radioaktiva läkemedelITM Medical Isotopes GmbH
- IrelandEndolucinBeta 40 GBq/mL radiopharmaceutical precursor, solutionITM Medical Isotopes GmbH
- GermanyLutencaCurium Romania Srl
Authorised across Europe · EMA
The same active substance is authorised in 13 EEA countries. Names it is sold under:
- Austria · Lutenca
- Belgium · Monlutenca
- Germany · Lutenca
- Spain · Lutenca
- France · Lunca
- United Kingdom (Northern Ireland) · Monlutenca
- Iceland · Endolucinbeta, Ilumira
- Italy · Monlunca
- Liechtenstein · Endolucinbeta, Ilumira
- Netherlands · Monlutenca
- Norway · Endolucinbeta, Ilumira
- Portugal · Lutenca
- Sweden · Lutenca
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/853d74eb-ad1e-4fa2-a722-8458547a0b5d GET /v1/drugs/853d74eb-ad1e-4fa2-a722-8458547a0b5d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Prekursor radiofarmaceutyku, roztwór",
"source": "urpl",
"strength": "37 GBq/ml",
"packaging": "Rpz ¦ EU/1/26/2018/001 ¦ 166735\n1 fiol. 2 ml\nRpz ¦ EU/1/26/2018/002 ¦ 166736\n2 fiol. 2 ml\nRpz ¦ EU/1/26/2018/003 ¦ 166737\n3 fiol. 2 ml\nRpz ¦ EU/1/26/2018/004 ¦ 166738\n4 fiol. 2 ml\nRpz ¦ EU/1/26/2018/005 ¦ 166739\n1 fiol. 10 ml\nRpz ¦ EU/1/26/2018/006 ¦ 166740\n2 fiol. 10 ml\nRpz ¦ EU/1/26/2018/007 ¦ 166741\n3 fiol. 10 ml\nRpz ¦ EU/1/26/2018/008 ¦ 166742\n4 fiol. 10 ml",
"substance": "Lutetii (177Lu) Chloridum 37 GBq/ml",
"common_name": "Lutetium (177Lu) Chloride",
"pl_product_id": "100536407",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about lutetium (177lu) chloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.